Prediction of Drug-Induced Hyperbilirubinemia by In Vitro Testing
Bilirubin, the end product of heme catabolism, is produced continuously in the body and may reach toxic levels if accumulates in the serum and tissues; therefore, a highly efficient mechanism evolved for its disposition. Normally, unconjugated bilirubin enters hepatocytes through the uptake transpor...
Main Authors: | Péter Tátrai, Péter Krajcsi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/8/755 |
Similar Items
-
Curated human hyperbilirubinemia data and the respective OATP1B1 and 1B3 inhibition predictions
by: Eleni Kotsampasakou, et al.
Published: (2017-04-01) -
Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
by: Naidoo A, et al.
Published: (2017-08-01) -
Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
by: Chalirmporn Atasilp, et al.
Published: (2022-05-01) -
Do Gene Polymorphisms Play a Role in Newborn Hyperbilirubinemia?
by: Hakan N, et al.
Published: (2024-03-01) -
An Epileptic Patient with Recurrent Hyperbilirubinemia Caused by Gilbert Syndrome
by: Yaoyao Zhang, et al.
Published: (2020-01-01)